InvestorsHub Logo
Followers 35
Posts 731
Boards Moderated 0
Alias Born 07/17/2013

Re: BiotechValues post# 4953

Friday, 08/16/2013 4:24:32 PM

Friday, August 16, 2013 4:24:32 PM

Post# of 81999
The dilution of shares is what killed the run. Because of the high number of shares the market cap is a bit high for this stock. The fact is the volume has flattened and will remain that way until a strong catalyst occurs. Real news, not some bs MOU with another company. So my contention is that this stock will remain sideways for a while. Most investors are simply on the sidelines waiting and watching for the next run to begin and then they will jump in on the momentum. The question is when will that be. I believe this stock is still fairly undiscovered. Organovo continues to go up since the correction and Arcam has been killing it. Sigma should be following suit but people are just scared after the recent crash.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SASI News